Clinical Trial

Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is determine if a plant-based resistant starch that is optimized for the individual will target the underlying cause of inflammatory bowel disease and restore a "healthier" gut microbiome in pediatric participants with inflammatory bowel disease.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-08-19; most recent amendment 2026-01-28.
Status change: Recruiting → Active, Not Recruiting 2023-05-26
Status change: Not Yet Recruiting → Recruiting 2020-09-01
Trial Details
NCT Number NCT04522271
Lead Sponsor Children's Hospital of Eastern Ontario
Conditions Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Enrollment 80 participants
Start Date 2020-08-25
Primary Completion 2024-05-25 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-29